Recursion Pharmaceuticals Inc Cl A
(RXRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 662,972 | 528,216 | 503,528 | 597,395 | 429,202 |
| Receivables | 21,910 | 21,606 | 46,124 | 49,166 | 2,255 |
| Other current assets | 29,223 | 37,338 | 32,023 | 38,107 | 42,715 |
| TOTAL | $714,105 | $587,160 | $584,145 | $714,269 | $474,172 |
| Non-Current Assets | |||||
| PPE Net | 111,706 | 120,038 | 126,834 | 141,063 | 84,410 |
| Intangibles | 484,386 | 505,589 | 493,902 | 484,728 | 86,149 |
| Other Non-Current Assets | 89,329 | 89,568 | 100,353 | 108,538 | 81,768 |
| TOTAL | $685,421 | $715,195 | $721,089 | $734,329 | $252,327 |
| Total Assets | $1,399,526 | $1,302,355 | $1,305,234 | $1,448,598 | $726,499 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,935 | 19,314 | 25,086 | 21,613 | 2,260 |
| Accrued Expenses | 73,360 | 84,538 | 56,804 | 81,872 | 40,597 |
| Other current liabilities | 47,364 | 39,690 | 39,651 | 61,767 | 49,579 |
| TOTAL | $155,103 | $164,026 | $141,981 | $187,472 | $108,888 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,902 | 14,196 | 16,446 | 19,022 | 20,510 |
| Other Non-Current Liabilities | 162,261 | 181,203 | 190,423 | 190,747 | 72,374 |
| TOTAL | $197,475 | $219,183 | $229,306 | $226,344 | $93,052 |
| Total Liabilities | $352,578 | $383,209 | $371,287 | $413,816 | $201,940 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 520,643 | 434,152 | 406,495 | 401,991 | 286,641 |
| Common Shares | 5 | 4 | 4 | 4 | 3 |
| Retained earnings | -1,967,879 | -1,805,589 | -1,633,694 | -1,431,283 | -1,252,377 |
| Other shareholders' equity | 34,093 | 43,620 | 14,145 | -7,637 | 0 |
| TOTAL | $1,046,948 | $919,146 | $933,947 | $1,034,782 | $524,559 |
| Total Liabilities And Equity | $1,399,526 | $1,302,355 | $1,305,234 | $1,448,598 | $726,499 |